PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
22.06%
Positive growth while CRON.TO shows revenue decline. John Neff would investigate competitive advantages.
3.79%
Cost increase while CRON.TO reduces costs. John Neff would investigate competitive disadvantage.
127.38%
Gross profit growth 50-75% of CRON.TO's 199.28%. Martin Whitman would scrutinize competitive position.
86.29%
Margin expansion below 50% of CRON.TO's 238.42%. Michael Burry would check for structural issues.
271.70%
R&D growth while CRON.TO reduces spending. John Neff would investigate strategic advantage.
19.72%
G&A growth while CRON.TO reduces overhead. John Neff would investigate operational differences.
21.75%
Marketing expense growth 1.25-1.5x CRON.TO's 16.01%. Martin Whitman would scrutinize spending rationale.
-264.15%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
37.01%
Operating expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
12.96%
Total costs growth while CRON.TO reduces costs. John Neff would investigate differences.
161.68%
Interest expense change of 161.68% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
-3.39%
Both companies reducing D&A. Martin Whitman would check industry patterns.
113.41%
EBITDA growth exceeding 1.5x CRON.TO's 43.74%. David Dodd would verify competitive advantages.
1752.23%
EBITDA margin growth exceeding 1.5x CRON.TO's 36.38%. David Dodd would verify competitive advantages.
38.32%
Operating income growth 50-75% of CRON.TO's 66.23%. Martin Whitman would scrutinize operations.
49.46%
Similar operating margin growth to CRON.TO's 61.81%. Walter Schloss would investigate industry trends.
-674.13%
Other expenses reduction while CRON.TO shows 49.75% growth. Joel Greenblatt would examine advantage.
60.13%
Pre-tax income growth below 50% of CRON.TO's 895.34%. Michael Burry would check for structural issues.
67.33%
Pre-tax margin growth below 50% of CRON.TO's 1025.52%. Michael Burry would check for structural issues.
-862.35%
Tax expense reduction while CRON.TO shows 174.00% growth. Joel Greenblatt would examine advantage.
65.75%
Net income growth below 50% of CRON.TO's 423.76%. Michael Burry would check for structural issues.
71.94%
Net margin growth below 50% of CRON.TO's 492.27%. Michael Burry would check for structural issues.
66.67%
EPS growth below 50% of CRON.TO's 404.59%. Michael Burry would check for structural issues.
66.67%
Diluted EPS growth below 50% of CRON.TO's 404.59%. Michael Burry would check for structural issues.
5.20%
Share count change of 5.20% while CRON.TO is stable. Bruce Berkowitz would verify approach.
5.20%
Diluted share change of 5.20% while CRON.TO is stable. Bruce Berkowitz would verify approach.